2019 Annual Meeting | IS1 - Invited Science: Infectious Diseases and Global Health
Program Materials Program Evaluations
| 01:00 PM - 01:10 PM EDT | Introduction |
Welcome to Invited Science
Kiran Thakur, MD, FAAN, John D. England, MD, FAAN |
| 01:10 PM - 01:25 PM EDT | Speaker |
Acute Encephalitis Syndrome in Eastern Uttar Pradesh, India: Changing Etiological Understanding
Manoj Murhekar, MD, MBBS |
| 01:25 PM - 01:40 PM EDT | Speaker |
Molecular and Serological Discovery in CNS Infectious Diseases
Nischay Mishra, PhD |
| 01:40 PM - 01:45 PM EDT | Q&A |
Questions
|
| 01:45 PM - 02:00 PM EDT | Speaker |
Clinical and Epidemiological Features of Enterovirus-Associated Acute Flaccid Myelitis
Kevin Messacar, MD |
| 02:00 PM - 02:15 PM EDT | Speaker |
EV-D68: Lessons from Murine Models and Neuronal Cell Culture
Kenneth L. Tyler, MD, FAAN |
| 02:15 PM - 02:20 PM EDT | Q&A |
Questions
|
| 02:20 PM - 02:35 PM EDT | Speaker |
Tapping into CNS Reservoirs: Single Cell RNA Sequencing of CSF in HIV
Serena Spudich, MD |
| 02:35 PM - 02:40 PM EDT | Q&A |
Questions
|
| 02:40 PM - 02:55 PM EDT | Speaker |
Viral Triggers of Autoimmune Encephalitis
Josep O. Dalmau, MD, PhD, FAAN |
| 02:55 PM - 03:00 PM EDT | Discussion |
Final Discussion and Q&A
|
| Kiran Thakur, MD, FAAN | The institution of Dr. Thakur has received research support from Center for Disease Control and Prevention. |
| Kenneth L. Tyler, MD, FAAN | Dr. Tyler has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Protagonist Therapeutics, Newark CA. Dr. Tyler has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association/Wiley. Dr. Tyler has received intellectual property interests from a discovery or technology relating to health care. Dr. Tyler has received publishing royalties from a publication relating to health care. Dr. Tyler has a non-compensated relationship as a Director (ex officio) with American Neurological association that is relevant to AAN interests or activities. Dr. Tyler has a non-compensated relationship as a Director with International Society for Neurovirology that is relevant to AAN interests or activities. |
| Kevin Messacar, MD | No disclosure on file |
| Nischay Mishra, PhD | Dr. Mishra has nothing to disclose. |
| Manoj Murhekar, MD, MBBS | No disclosure on file |
| John D. England, MD, FAAN | Dr. England has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. England has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. The institution of Dr. England has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. |
| Serena Spudich, MD | The institution of Dr. Spudich has received research support from NIH. |
| Josep O. Dalmau, MD, PhD, FAAN | Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. |